Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationCombined Modality TherapyBone MarrowCyclophosphamideBone Marrow TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisBone Marrow CellsHematopoietic Stem CellsStem CellsTransplantation, HomologousTreatment OutcomeBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsAntineoplastic AgentsLymphoma, Non-HodgkinGraft vs Host DiseaseMelphalanBone and BonesGraft SurvivalMultiple MyelomaStem Cell TransplantationSalvage TherapyBusulfanBlood CellsBone Marrow DiseasesBlood Cell CountChemotherapy, AdjuvantEtoposideHematopoiesisCord Blood Stem Cell TransplantationAntineoplastic Agents, AlkylatingBone Marrow PurgingTissue DonorsThiotepaRecurrenceMyeloablative AgonistsWhole-Body IrradiationTransplantation ChimeraDisease-Free SurvivalTime FactorsIfosfamideRemission InductionLeukemiaHistocompatibilityCytarabineColony-Forming Units AssayFlow CytometrySurvival RateDoxorubicinDose-Response Relationship, DrugPlatelet CountCell DifferentiationSurvival AnalysisCell SeparationHistocompatibility TestingCells, CulturedLeukocyte CountBlood DonorsRecombinant ProteinsLeukemia, Myeloid, AcuteAnemia, AplasticImmunophenotypingNeoplasmsHodgkin DiseaseEmbryonic Stem CellsInfectionLeukocytes, MononuclearVidarabineTransplantation, IsogeneicAdult Stem CellsLymphomaBone RemodelingCarmustineImmunosuppressive AgentsPOEMS SyndromeVincristineRetrospective StudiesImmunomagnetic SeparationAntigens, CDBone Marrow ExaminationStem Cell FactorCarboplatinT-LymphocytesHematologic DiseasesBreast NeoplasmsBone Marrow NeoplasmsBone NeoplasmsMethotrexateMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesProchlorperazineFollow-Up Studies